This seems to be specific for liver steatosis, as suggested by Chishima et al. [43] in a study of Japanese patients with NAFLD or Hepatitis C virus (HCV) chronic liver disease where IGF-1 levels were decreased in patients with NAFLD but not with HCV. This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.